Jeffrey S. Martini - Dec 13, 2024 Form 4 Insider Report for PALVELLA THERAPEUTICS, INC. (PVLA)

Role
Chief Scientific Officer
Signature
Kathleen A. McGowan, Attorney-in-Fact
Stock symbol
PVLA
Transactions as of
Dec 13, 2024
Transactions value $
$0
Form type
4
Date filed
12/17/2024, 08:44 PM
Next filing
Feb 10, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PVLA Stock Option (right to buy) Award $0 +126K $0.00 126K Dec 13, 2024 Common Stock 126K $13.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options will vest in equal monthly tranches over 48 months.